Patient Guide: Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 90 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05605899
Status: 🟢 Enrolling Now
Condition: High-risk Large B-cell Lymphoma (LBCL)
Phase: PHASE3

Where You Can Participate

This study is available at 90 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Gilbert, Arizona
  • • Phoenix, Arizona
  • • And 87 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma - Join Clinical Trial NCTNCT05605899

How to Join This Clinical Trial - NCTNCT05605899

Learn how to participate in this PHASE3 trial studying an investigational therapy for High-risk Large B-cell Lymphoma (LBCL). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with High-risk Large B-cell Lymphoma (LBCL). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
High-risk Large B-cell Lymphoma (LBCL)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05605899 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 90 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35233 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Gilbert, Arizona 85234 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Phoenix, Arizona 85054 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

La Jolla, California 92093 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Los Angeles, California 90095 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Palo Alto, California 94305 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Denver, Colorado 80218 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Tampa, Florida 33612 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Augusta, Georgia 30912 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Chicago, Illinois 60612 - United States

Status: ACTIVE_NOT_RECRUITING

And 80 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for High-risk Large B-cell Lymphoma (LBCL):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships